Get started
Work

A randomized non-inferiority trial of an eHealth delivery alternative for cancer genetic testing for hereditary cancer (eREACH2).

Year: 2026
Type: conference-abstract
DOI: 10.1200/jco.2026.44.16_suppl.10510
Authors: Kimberley T. Lee, Brian Lee Egleston, Dominique Fetzer, Sarah Brown, Susan M. Domchek, Linda Fleisher, Kuang-Yi Wen, Lynne I. Wagner, J. Scott Roberts, Cara Cacioppo, Janice Christiansen, Sarah Howe, Elisabeth Wood, Michelle Weinberg, Kelsey Karpink, Enida F. Selmani, Justin Feng, Samantha John, Evelyn Mastaglio, Angela R. Bradbury, eREACH2 Group
Institutions: University of Pennsylvania, Fox Chase Cancer Center, University of Pennsylvania Health System, Abramson Cancer Center, Thomas Jefferson University, Sidney Kimmel Cancer Center, University of North Carolina at Chapel Hill, University of Michigan
Language: English
Subfield: Genetics
Open Access status: closed
OpenAlex ID: W7162496663
Cites: 28
Cited by:
Related to: